137 related articles for article (PubMed ID: 9671178)
1. Identification of deletions and insertions in the p53 gene using multiplex PCR and high-resolution fragment analysis: application to breast and ovarian tumors.
Angelopoulou K; Diamandis EP
J Clin Lab Anal; 1998; 12(4):250-6. PubMed ID: 9671178
[TBL] [Abstract][Full Text] [Related]
2. Exon 5 of the p53 gene is a target for deletions in ovarian cancer.
Angelopoulou K; Levesque MA; Katsaros D; Shipman R; Diamandis EP
Clin Chem; 1998 Jan; 44(1):72-7. PubMed ID: 9550561
[TBL] [Abstract][Full Text] [Related]
3. Rapid sequencing of the p53 gene with a new automated DNA sequencer.
Bharaj BS; Angelopoulou K; Diamandis EP
Clin Chem; 1998 Jul; 44(7):1397-403. PubMed ID: 9665415
[TBL] [Abstract][Full Text] [Related]
4. Multiplex PCR screening detects small p53 deletions and insertions in human ovarian cancer cell lines.
Runnebaum IB; Tong XW; Moebus V; Heilmann V; Kieback DG; Kreienberg R
Hum Genet; 1994 Jun; 93(6):620-4. PubMed ID: 8005584
[TBL] [Abstract][Full Text] [Related]
5. Rapid detection of novel BRCA1 rearrangements in high-risk breast-ovarian cancer families using multiplex PCR of short fluorescent fragments.
Casilli F; Di Rocco ZC; Gad S; Tournier I; Stoppa-Lyonnet D; Frebourg T; Tosi M
Hum Mutat; 2002 Sep; 20(3):218-26. PubMed ID: 12203994
[TBL] [Abstract][Full Text] [Related]
6. Is it possible to diagnose malignancy from fluid in cystic ovarian tumors?
Yamada R; Maeda N; Oguri H; Adachi Y; Takeuchi T; Furihata M; Fukaya T
Eur J Obstet Gynecol Reprod Biol; 2013 Nov; 171(1):96-100. PubMed ID: 24017961
[TBL] [Abstract][Full Text] [Related]
7. Novel polymerase chain reaction approach for full-coding p53 mutation detection in microdissected archival tumors.
Thompson-Hehir J; Davies MP; Green JA; Halliwell N; Joyce KA; Salisbury J; Sibson DR; Vergote I; Walker C
Diagn Mol Pathol; 2000 Jun; 9(2):110-9. PubMed ID: 10850547
[TBL] [Abstract][Full Text] [Related]
8. Alternative splicing of the p53 tumor suppressor gene in the Molt-4 T-lymphoblastic leukemia cell line.
Chow VT; Quek HH; Tock EP
Cancer Lett; 1993 Sep; 73(2-3):141-8. PubMed ID: 8221626
[TBL] [Abstract][Full Text] [Related]
9. Novel genomic rearrangements in the BRCA1 gene detected in Greek breast/ovarian cancer patients.
Armaou S; Konstantopoulou I; Anagnostopoulos T; Razis E; Boukovinas I; Xenidis N; Fountzilas G; Yannoukakos D
Eur J Cancer; 2007 Jan; 43(2):443-53. PubMed ID: 17174087
[TBL] [Abstract][Full Text] [Related]
10. An intronic deletion in TP53 gene causes exon 6 skipping in breast cancer.
Voglino G; Castello S; Silengo L; Stefanuto G; Friard O; Ferrara G; Fessia L
Eur J Cancer; 1997 Aug; 33(9):1479-83. PubMed ID: 9337692
[TBL] [Abstract][Full Text] [Related]
11. Mutation profile of the p53, fhit, p16INK4a/p19ARF and H-ras genes in Indian breast carcinomas.
Kannan K; Krishnamurthy J; Feng J; Nakajima T; Tsuchida N; Shanmugam G
Int J Oncol; 2000 Nov; 17(5):1031-5. PubMed ID: 11029509
[TBL] [Abstract][Full Text] [Related]
12. Deletion of exons 1a-2 of BRCA1: a rather frequent pathogenic abnormality.
van den Ouweland AM; Dinjens WN; Dorssers LC; van Veghel-Plandsoen MM; Brüggenwirth HT; Withagen-Hermans CJ; Collée JM; Joosse SA; Terlouw-Kromosoeto JN; Nederlof PM
Genet Test Mol Biomarkers; 2009 Jun; 13(3):399-406. PubMed ID: 19405878
[TBL] [Abstract][Full Text] [Related]
13. High occurrence of BRCA1 intragenic rearrangements in hereditary breast and ovarian cancer syndrome in the Czech Republic.
Vasickova P; Machackova E; Lukesova M; Damborsky J; Horky O; Pavlu H; Kuklova J; Kosinova V; Navratilova M; Foretova L
BMC Med Genet; 2007 Jun; 8():32. PubMed ID: 17561994
[TBL] [Abstract][Full Text] [Related]
14. Detection of p53 gene mutations in human ovarian and endometrial cancers by polymerase chain reaction-single strand conformation polymorphism analysis.
Naito M; Satake M; Sakai E; Hirano Y; Tsuchida N; Kanzaki H; Ito Y; Mori T
Jpn J Cancer Res; 1992 Oct; 83(10):1030-6. PubMed ID: 1333465
[TBL] [Abstract][Full Text] [Related]
15. Screening for genomic rearrangements in BRCA1 and BRCA2 genes in Czech high-risk breast/ovarian cancer patients: high proportion of population specific alterations in BRCA1 gene.
Ticha I; Kleibl Z; Stribrna J; Kotlas J; Zimovjanova M; Mateju M; Zikan M; Pohlreich P
Breast Cancer Res Treat; 2010 Nov; 124(2):337-47. PubMed ID: 20135348
[TBL] [Abstract][Full Text] [Related]
16. p53 and Ki-ras gene mutations in epithelial ovarian neoplasms.
Teneriello MG; Ebina M; Linnoila RI; Henry M; Nash JD; Park RC; Birrer MJ
Cancer Res; 1993 Jul; 53(13):3103-8. PubMed ID: 8319218
[TBL] [Abstract][Full Text] [Related]
17. Identification of novel breast tumor-specific mutation(s) in the q11.2 region of chromosome 17 by RAPD/AP-PCR fingerprinting.
Singh KP; Roy D
Gene; 2001 May; 269(1-2):33-43. PubMed ID: 11376935
[TBL] [Abstract][Full Text] [Related]
18. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
Durocher F; Labrie Y; Soucy P; Sinilnikova O; Labuda D; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Ouellette G; Pichette R; Plante M; Tavtigian SV; Simard J
BMC Cancer; 2006 Sep; 6():230. PubMed ID: 17010193
[TBL] [Abstract][Full Text] [Related]
19. Spectrum of mutation and frequency of allelic deletion of the p53 gene in ovarian cancer.
Kohler MF; Marks JR; Wiseman RW; Jacobs IJ; Davidoff AM; Clarke-Pearson DL; Soper JT; Bast RC; Berchuck A
J Natl Cancer Inst; 1993 Sep; 85(18):1513-9. PubMed ID: 8360934
[TBL] [Abstract][Full Text] [Related]
20. p53 gene mutations in gastric cancer metastases and in gastric cancer cell lines derived from metastases.
Yamada Y; Yoshida T; Hayashi K; Sekiya T; Yokota J; Hirohashi S; Nakatani K; Nakano H; Sugimura T; Terada M
Cancer Res; 1991 Nov; 51(21):5800-5. PubMed ID: 1933850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]